All In MedTech

FDA Clearance Tracker · P030028-S005

ARTISAN/VERISYSE MYOPIA PHAKIC INTRAOCULAR LENS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 20, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 20, 2018

Approved

Time to decision

574 days

Received Jan 23, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030028-S005
Device name
ARTISAN/VERISYSE MYOPIA PHAKIC INTRAOCULAR LENS
Applicant
Ophtec BV
Applicant location
Groningen
Received
Jan 23, 2017
Decided
Aug 20, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P030028

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MTA

FDA's approval statement

As written in FDA's record.

Approval for modifying the physician and patient labeling to include the results from the extended follow-up post-approval study.

Source documents

Other decisions for Ophtec BV

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.